Bioethics Biotechnology Events Featured Genetics Health Information Technology Health Law Policy Workshop History Intellectual Property Jorge Contreras Petrie-Flom Center Supreme Court
patents
-
-
Featured Generic Drugs Greg Curfman Health Law Policy Intellectual Property Judicial Opinions Pharmaceuticals Public HealthFatty Acids, Skinny Labels: Fish Oil Patent Battle Back in Court
Read more: Fatty Acids, Skinny Labels: Fish Oil Patent Battle Back in Court -
Featured Greg Curfman Intellectual Property Judicial Opinions Medical devices Pharmaceuticals Supreme CourtThe Patent Trial and Appeal Board Again Survives Supreme Court Review
Read more: The Patent Trial and Appeal Board Again Survives Supreme Court Review -
COVID and the Law FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence Vaccines“Stick to the Science”? FDA, Ethics, and Pandemics
Read more: “Stick to the Science”? FDA, Ethics, and Pandemics -
The Patent Trial and Appeal Board Returns to the Supreme Court
Read more: The Patent Trial and Appeal Board Returns to the Supreme Court -
Antitrust Featured Generic Drugs Greg Curfman Health Law Policy Intellectual Property Pharmaceuticals Public Health3 Challenges to Patents on Therapeutic Monoclonal Antibodies
Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies -
Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported?
Read more: Pharmaceutical Patents on Manufacturing Methods: Groundless or Well-Supported? -
When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims
Read more: When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims -
COVID and the Law FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence VaccinesFrom 9/11 to COVID-19: A Brief History of FDA Emergency Use Authorization
Read more: From 9/11 to COVID-19: A Brief History of FDA Emergency Use Authorization -
AbbVie Wins First Round in Humira Antitrust Lawsuit
Read more: AbbVie Wins First Round in Humira Antitrust Lawsuit